Skip Navigation

European Heart Journal 2003 24(15):1430-1436; doi:10.1016/S0195-668X(03)00261-6
Copyright © 2003 by the European Society of Cardiology.
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (40)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Grönefeld, G. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grönefeld, G. C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Regular Articles

Impact of rate versus rhythm control on quality of life in patients with persistent atrial fibrillation

Results from a prospective randomized study

Gerian C. Grönefelda, Jürgen Lilienthalb, Karl-Heinz Kuckc and Stefan H. Hohnlosera,* for the Pharmacological Intervention in Atrial Fibrillation (PIAF) Study Investigators

a J.W. Goethe University, Department of Medicine, Division of Cardiology, Frankfurt, Germany
b Datamap GmbH, Freiburg, Germany
c St. Georg Hospital, Hamburg, Germany

* Correspondence to: Stefan H. Hohnloser, MD, FESC, FACC, J.W. Goethe University, Dept. of Medicine, Division of Cardiology, Theodor-Stern-Kai 7, 60590 Frankfurt am Main. Tel.: +49.69.6301-7404; fax: +49.69.6301-7017
E-mail address: hohnloser{at}em.uni-frankfurt.de

Received 19 January 2003; revised 10 March 2003; accepted 9 April 2003

Aims Despite the high prevalence of atrial fibrillation (AF), there are only limited data on quality of life (QoL) stemming from prospective trials comparing rate versus rhythm control. This prospective study evaluated QoL in patients with symptomatic persistent AF randomized to therapy aiming at rate versus rhythm control.

Methods and results Patients with symptomatic persistent AF (7 to 360 days duration) were prospectively randomized to ventricular rate control (n=125) or to cardioversion and maintenance of sinus rhythm (n=127). QoL was assessed by the Medical Outcomes Study Short Form health survey (SF-36) at baseline and during 1 year of follow-up. Changes in QoL were compared on an intent-to-treat basis, and subsequently between patients in sinus rhythm versus AF. At baseline, all SF-36 scales were reduced compared to healthy controls. At 1 year, six of eight items had improved significantly in patients assigned to rate control, and five of eight items on rhythm control (p=ns). The physical component summary showed a comparable increase with both treatment strategies (rate control: p=0.004; rhythm control: p<0.001) whereas no significant changes were found for the mental component summary. At 1 year, 55% of patients reported a positive health transition with no inter-group differences. There were no significant differences in QoL in patients in sinus rhythm or AF at the end of the observation period.

Conclusion In patients with symptomatic persistent AF, the two treatment strategies of rate versus rhythm control are associated with similar improvements in QoL.

Key Words: Atrial fibrillation • Quality of life • Controlled clinical trials


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
BMJHome page
T. R Betts
Is rate more important than rhythm in treating atrial fibrillation? Yes
BMJ, August 21, 2009; 339(aug21_1): b3173 - b3173.
[Full Text]


Home page
Circ Arrhythm ElectrophysiolHome page
P. Dorian, P. G. Guerra, C. R. Kerr, S. S. O'Donnell, E. Crystal, A. M. Gillis, L. B. Mitchell, D. Roy, A. C. Skanes, M. S. Rose, et al.
Validation of a New Simple Scale to Measure Symptoms in Atrial Fibrillation: The Canadian Cardiovascular Society Severity in Atrial Fibrillation Scale
Circ Arrhythm Electrophysiol, June 1, 2009; 2(3): 218 - 224.
[Abstract] [Full Text] [PDF]


Home page
Br Med BullHome page
A. Bajpai, I. Savelieva, and A. J. Camm
Treatment of atrial fibrillation
Br. Med. Bull., December 5, 2008; (2008) ldn046v1.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
A J Camm, I Savelieva, G Y H Lip, and on behalf of the Guideline Development Group for t
Rate control in the medical management of atrial fibrillation
Heart, January 1, 2007; 93(1): 35 - 38.
[Full Text] [PDF]


Home page
EuropaceHome page
Writing Committee Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al.
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Europace, September 1, 2006; 8(9): 651 - 745.
[Full Text] [PDF]


Home page
HeartHome page
A Nergardh and M Frick
Perceived heart rhythm in relation to ECG findings after direct current cardioversion of atrial fibrillation
Heart, September 1, 2006; 92(9): 1244 - 1247.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
J. Am. Coll. Cardiol., August 15, 2006; 48(4): 854 - 906.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
J. Am. Coll. Cardiol., August 15, 2006; 48(4): e149 - e246.
[Full Text] [PDF]


Home page
CirculationHome page
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Circulation, August 15, 2006; 114(7): e257 - e354.
[Full Text] [PDF]


Home page
CirculationHome page
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Circulation, August 15, 2006; 114(7): 700 - 752.
[Full Text] [PDF]


Home page
Eur Heart JHome page
Authors/Task Force Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al.
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation executive summary: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Eur. Heart J., August 2, 2006; 27(16): 1979 - 2030.
[Full Text] [PDF]


Home page
Eur Heart JHome page
C. J. Boos, R. A. Anderson, and G. Y.H. Lip
Is atrial fibrillation an inflammatory disorder?
Eur. Heart J., January 2, 2006; 27(2): 136 - 149.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
L. Testa, G. G.L. Biondi-Zoccai, A. D. Russo, F. Bellocci, F. Andreotti, and F. Crea
Rate-control vs. rhythm-control in patients with atrial fibrillation: a meta-analysis
Eur. Heart J., October 1, 2005; 26(19): 2000 - 2006.
[Abstract] [Full Text] [PDF]


Home page
Am J Crit CareHome page
L. G. Futterman and L. Lemberg
Atrial Fibrillation
Am. J. Crit. Care., September 1, 2005; 14(5): 438 - 440.
[Full Text] [PDF]


Home page
CirculationHome page
R. H. Falk
Rate Control Is Preferable to Rhythm Control in the Majority of Patients With Atrial Fibrillation
Circulation, June 14, 2005; 111(23): 3141 - 3150.
[Full Text] [PDF]


Home page
EuropaceHome page
P. Zohar, M. Kovacic, M. Brezocnik, and M. Podbregar
Prediction of maintenance of sinus rhythm after electrical cardioversion of atrial fibrillation by non-deterministic modelling
Europace, January 1, 2005; 7(5): 500 - 507.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
D. A. Marshall, A. R. Levy, H. Vidaillet, E. Fenwick, A. Slee, G. Blackhouse, H. L. Greene, D. G. Wyse, G. Nichol, B. J. O'Brien, et al.
Cost-Effectiveness of Rhythm versus Rate Control in Atrial Fibrillation
Ann Intern Med, November 2, 2004; 141(9): 653 - 661.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
P. Dorian, I. Mangat, A. Pinter, and V. Korley
The Burden of Atrial Fibrillation: Should We Abandon Antiarrhythmic Drug Therapy?
Journal of Cardiovascular Pharmacology and Therapeutics, October 1, 2004; 9(4): 257 - 262.
[Abstract] [PDF]


Home page
Eur Heart JHome page
V. E. Hagens, K. M. Vermeulen, E. M. TenVergert, D. J. Van Veldhuisen, H. A. Bosker, O. Kamp, J. H. Kingma, J. G.P. Tijssen, H. J.G.M. Crijns, I. C. Van Gelder, et al.
Rate control is more cost-effective than rhythm control for patients with persistent atrial fibrillation -- results from the RAte Control versus Electrical cardioversion (RACE) study
Eur. Heart J., September 1, 2004; 25(17): 1542 - 1549.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. W. Israel, G. Gronefeld, J. R. Ehrlich, Y.-G. Li, and S. H. Hohnloser
Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: Implications for optimal patient care
J. Am. Coll. Cardiol., January 7, 2004; 43(1): 47 - 52.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.